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ABSTRACT 
In past there have been many medicinal plants, which have been used in traditional medicines for their antihyperglycemic properties 
without any scientific support and pharmacological evidence. The aqueous extract of Withania coagulans dunal fruit has been taken 
to evaluate the antihyperglycemic activity in normal and streptozotocin-induced diabetic rats. The plant is known as ‘the cheese 
maker’ or ‘vegetable rennet’ because fruits and leaves of the plant are used as a coagulant. The milk coagulating property of the fruit 
is attributed to the pulp and husk berries which posses an enzyme which has milk coagulating activity an antihyperglycemic activity 
of aqueous extract has not been yet done, as no such reports are available in the literature through the activity is reported. The 
scientific evaluation of its antihyperglycemic activity was, therefore, explored and also compared with the effect of a standard 
hypoglycemic drug, glibenclamide. A single oral administration of variable dose levels (100, 200 and 300 mg/kg b.wt) of aqueous 
extract led to lowering of blood glucose level in normal as well as in diabetic rats. In acute treatment maximum % reduction in 
glucose level (57.02%) was seen with 300mg/kg b. wt WCD at 6 hr while with standard drug maximum % reduction (62.25%) at 6 
hr was found. In subacute study the maximum % reduction in blood glucose level was found (57.22%) with WCD aq. extract in dose 
300 mg/kg b. wt which is slightly lesser then the % reduction seen with standard drug (64.52%) respectively. Both the doses 100 & 
200 mg/kg b. wt of WCD showed significant effect (p<.05) at 4 hr and highly significant (p<0.01) at 6 hr while in chronic treatment 
both the doses showed significant reduction in blood glucose from 14th day to 28th days. The findings from this study suggest that the 
aqueous extract of these fruits may be prescribed as adjunct to dietary therapy and drug treatment for controlling diabetes mellitus. 
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1. INTRODUCTION 
Diabetes currently is a major health problem for the 
people of the world. Diabetes is a chronic disorder of 
carbohydrate, fat and protein metabolism characterised 
by elevation of both fasting and post-paradinal blood 
sugar levels. The synthetic oral hypoglycemic agents can 
produce serious side effects. In addition, they are not 
considered to be safe for use during pregnancy. 
Furthermore, after the recommendation made by WHO 
on diabetes mellitus investigation on hypoglycemic 
agents from medicinal plants have become more 
important
1-4
. 
W. coagulans (family: Solanaceae) is commonly known 
as ‘Panir ke phool’ in Hindi and is widely and regularly 
used in India and other tropical countries. W. coagulans 
dunal is very well known for its ethno pharmacological 
activities. In Punjab, the fruits of W. coagulans are used 
as the source of coagulating enzyme for clotting the milk 
which is called ‘paneer’. Buffalo or sheep milk is 
warmed to about 100 ºF and crushed berries of plant, 
tied in cloth, are dipped in it. The milk takes 30-40 
minutes to curdle. The plant is known as ‘the cheese 
maker’ or ‘vegetable rennet’ because fruits and leaves of 
the plant are used as a coagulant. The milk coagulating 
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property of the fruit is attributed to the pulp and husk 
berries which posses an enzyme which has milk 
coagulating activity.
 
W. coagulans is used in chronic 
complaints of liver. A composite Ayurvedic herbal 
hepatoprotective medicine ‘Liv-52’ contains extracts of 
W. coagulans and W. somnifera. They are also used in 
diabetes, dyspepsia, flatulent colic and other intestinal 
infections. In some parts of Pak-Indian sub-continent, 
the berries are used as a blood purifier. The twigs are 
chewed for cleaning of teeth and the smoke of the plant 
is inhaled for relief in toothache
5-8
. 
The present study was undertaken to study the 
antihyperglycemic effect of aqueous extract of the fruits 
of W. coagulans in normal and streptozotocin induced 
diabetic rats. 
2. MATERIAL AND METHOD 
2.1. Plant material 
Fresh fruits of W. coagulans (3kg) were collected locally 
and got identified by Botanical survey of India, Jodhpur. 
The leaves were shade dried and were crushed to 
moderately coarse powder. 
2.2. Preparation of extract 
The powder was extracted with distilled water using 
soxhelt at boiling temperature (105 
◦
C) up to 9 h. A dark 
brown colour extract is obtained. This dark brown 
extract was cooled and filtered to remove the residue. 
The extract was concentrated on rotavapour under 
reduced pressure and then lyophilized to get a powder 
weighing about 4 g
9, 10, 11
. 
2.3. Experimental animals 
Male Albino wister rats weighing between 130 and 180 
g were used and were maintained on commercial diet 
and water ad libitum. They were acclimated to the 
laboratory conditions before carrying out any 
experimental work. Studies were carried out after the 
approval of Institutional Animal Ethical Committee in 
accordance with institutional ethical guidelines for the 
care of laboratory animals of Alwar Pharmacy College, 
Alwar, Raj, India (approval no.- APC/IEAC/2017/RP-
003). 
Diabetes mellitus was induced by administering 
intraperitonial injection of streptozotocin (45 mg/kg 
b.wt, Sigma chemicals, USA) dissolved in citrate buffer 
(pH 4.00) to the overnight fasted rats. Fasting blood 
glucose (FBG) level was checked regularly up to stable 
hyperglycemia after 7days of strpetozotocin 
administration. The blood glucose level (BGL) was 
determined by glucose oxidase method. The rats were 
divided in to different groups. The rats having FBG 
value greater than 250 mg/dl were considered. Rats that 
did not show any increase in FBG levels even initially 
after streptozotocin injection were considered as totally 
resistant and were excluded from studies. 
Antihyperglycemic activity was assessed by lowering of 
BGL in normal and diabetic rats
12-15
. 
2.4. Experimental design 
The experimental diabetes was induced in albino wistar 
rats by intra-peritoneal administration of streptozotocin. 
The rats were divided into six groups after the induction 
of diabetes. In the experiment 6 rats were uses in each 
group.  Aqueous extract of W. coagulans dunal fruits 
was given with the help of oral feeding tube to 
streptozotocin induce diabetic rats. 
2.4. Effect of W. coagulans extract on blood glucose 
level of rats (Acute Study and Sub Acute Study) 
In overnight, fasted rats FBG was checked and then they 
were divided into six groups of six rats each. Group I 
served as control and received vehicle (2 ml of normal 
saline) only. Group II served as diabetic control and 
received vehicle (2 ml of normal saline ), Groups III 
received standard drug glibenclamide and IV, V and VI 
were given aqueous fruits extract suspended in distilled 
water orally at doses 100, 200 and 300 mg/kg body 
weight, respectively. Blood samples were collected from 
the tail vein. 2, 4 and 6 h after giving the extract for 
acute study as well as  blood samples were collected 
from the tail vein. 7, 14, 21 and 28 days after giving the 
extract for subacute study. 
2.5. Statstical analysis 
The entire group data were statistically evaluated using 
student’s t-test, expressed as the mean ± S.D. from six 
rats in each group. P-value of 0.05 or less was 
considered to be significant. 
3. RESULTS 
Graph-1 and 2 shows the blood glucose levels of 
diabetic control, WCD aq. extract and glibenclamide 
treated rats. In diabetic control rats, the increase in blood 
glucose concentration was observed after 2hr and 
remained high throughout the study. Aq. extract of 
WCD (300 mg/kg b.wt.) and glibenclamide (600 µg/kg 
body wt.) treated rats showed significant decrease in 
blood glucose concentration when compared with 
diabetic control rats.  
Result obtained from WCD aq. extract indicate that 
WCD aq. extract at 300 mg/kg b.wt showed more 
significant (p<0.01) antidiabetic activity in acute as well 
as in chronic treatment when compared with diabetic 
control group. In acute treatment maximum % reduction 
in glucose level (57.02%) was seen with 300mg/kg b.wt 
WCD at 6 hr while with standard drug maximum % 
reduction (60.71%) at 6 hr was found. In chronic 
treatment the maximum % reduction in blood glucose 
level was found (59.44%) with WCD aq. Extract in dose 
300 mg/kg b.wt which is slightly lesser then the % 
reduction seen with standard drug (64.23%) 
respectively. Both the doses 100 & 200 mg/kg b.wt of 
WCD showed significant effect (p<.05) at 4 hr and 
highly significant (p<0.01) at 6 hr while in chronic 
treatment both the doses showed significant reduction in 
blood glucose from 14
th
 day to 28
th
 days. The 
antidiabetic studies of WCD aq. extract on 
streptozotocin induced diabetic rats showed that WCD 
posses highly significant antidiabetic effect with 
minimal toxicity at 300 mg/kg b.wt body weight as well 
as 200 mg/kg b.wt body weight and least activity at 100 
mg/kg b.wt body weight. 
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Table 1: Influence in blood glucose level of diabetic rat after treat them with Withania coagulans dunal aqueous 
extract and standard antidiabetic drug (0 hour, 1 hour, 3 hour, 5 hour and 7 hour) 
Group (n) 
Blood glucose level (mg/dl) 
0 hour 2 hour 4 hour 8 hour 24 hour 
NC 96±0.76 98±0.74 100±1.22 102±1.68 101±1.34 
DC 270±1.96 285±2.44 278±2.36 272±3.25 271±3.16 
WCD-300 276±5.26 221±5.27 208±4.51 196±4.49 188±4.02 
WCD-200 272±4.22 231±6.77 218±6.18 209±3.34 203±3.03 
WCD-100 280±5.26 242±6.80 233±5.81 224±6.38 222±6.41 
GLB-600 271±4.4 218±6.21 210±5.64 202±5.71 229±5.5 
 
Table 2: Influence in blood glucose level of diabetic rat after treat them with Withania coagulans dunal aqueous 
extract and standard antidiabetic drug (0 day, 7, 14, 21
 
& 28 day) 
Group (n) 
Blood glucose level (mg/dl) 
4
th
 day 7
th
 day 14
th
 day 21
st
 day 28
th
 day 
NC 104±1.03 103±1.76 104±1.94 102±1.86 101±1.54 
DC 290±3.18 294±3.94 295±3.79 298±2.5 295±3.22 
W.C.D-300 183±3.83 173±3.34 161±3.82 149±3.54 131±4.62 
WCD-200 204±3.39 201±3.12 194±3.54 184±4.26 173±4.26 
WCD-100 224±6.12 220±5.38 214±5.34 202±5.99 192±4.84 
GLB-600 206±4.16 163±4.02 141±2.85 122±2.13 109±2.88 
 
 
Graph- 1 Effect of different extract of W. coagulans on 
blood glucose level in streptozotocin induced diabetic 
rats for acute study 
 
Graph-2 Effect of different extract of W. coagulans on 
blood glucose level in streptozotocin induced diabetic 
rats for subacute study. 
4. DISCUSSION 
Streptozotocin causes massive reduction in insulin 
release, through the destruction of beta cells of islets of 
langerhens. In our study, we have observed a significant 
antidiabetic action of WCD aq. extract at 300 and 200 
mg/kg b.wt. This could be due to potentiation of the 
insulin effect of plasma by increasing the pancreatic 
secretion of insulin from existing beta cells of islets of 
langerhens or its release from bound insulin. The 
significant and consistent antidiabetic effect of WCD aq. 
extract in streptozotocin induce diabetic rats may also be 
due to enhanced glucose utilization by peripheral tissues. 
SGPT & SGOT are liver function test that give 
information about patients liver. Liver transaminase is 
useful biomarker of liver injury in a patient with a 
degree of intact liver function. Due to poor blood 
glucose control fat can deposited in liver, which may 
lead to rise in SGPT/SGOT.  
Hemoglobin HbA1c test also called HbA1c, Glycated 
hemoglobin test or glycohemoglobin is an important 
blood test that shows how diabetes is being controlled. 
HbA1c provides an average of blood sugar control over 
the past 2 to 3 months. Hemoglobin is found in RBC, 
which carry oxygen throughout body. When diabetes is 
not controlled then sugar build up in blood and combine 
with hemoglobin become Glycated.  
The conclusions derived from results revealed a defined 
role of the aqueous extract of W. coagulans fruits in 
suppressing blood glucose level in normal and diabetic 
rats. The aqueous extract in all the three doses produced 
significant hypoglycemic effect after 4 h administration. 
It is also clear that the hypoglycemic effect of variable 
dose of extract had begun 2 hours and was maximum at 
6 hours in all the groups. As far as most effective dose is 
concern it has been found to be 300 mg/kg b.wt in all the 
groups. This dose has almost same effect as of synthetic 
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drug glibenclamide. Further comprehensive pharma-
cological investigation is in progress to elucidate the 
exact mechanism of action of this extract. 
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